BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28299802)

  • 1. Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    Irshad S; Bansal M; Guarnieri P; Davis H; Al Haj Zen A; Baran B; Pinna CMA; Rahman H; Biswas S; Bardella C; Jeffery R; Wang LM; East JE; Tomlinson I; Lewis A; Leedham SJ
    J Pathol; 2017 Jun; 242(2):178-192. PubMed ID: 28299802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
    Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
    Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein receptor signal transduction in human disease.
    Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
    J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
    Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
    Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling.
    Choi S; Yu J; Park A; Dubon MJ; Do J; Kim Y; Nam D; Noh J; Park KS
    Sci Rep; 2019 Aug; 9(1):11724. PubMed ID: 31409851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.
    Chen X; Xiao W; Liu X; Zeng M; Luo L; Wu M; Ye S; Liu Y
    Curr Mol Med; 2014 May; 14(4):523-34. PubMed ID: 24694299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atonal homolog 1 is required for growth and differentiation effects of notch/gamma-secretase inhibitors on normal and cancerous intestinal epithelial cells.
    Kazanjian A; Noah T; Brown D; Burkart J; Shroyer NF
    Gastroenterology; 2010 Sep; 139(3):918-28, 928.e1-6. PubMed ID: 20621629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer.
    Le Corre D; Ghazi A; Balogoun R; Pilati C; Aparicio T; Martin-Lannerée S; Marisa L; Djouadi F; Poindessous V; Crozet C; Emile JF; Mulot C; Le Malicot K; Boige V; Blons H; de Reynies A; Taieb J; Ghiringhelli F; Bennouna J; Launay JM; Laurent-Puig P; Mouillet-Richard S
    EBioMedicine; 2019 Aug; 46():94-104. PubMed ID: 31377347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct bone morphogenetic proteins activate indistinguishable transcriptional responses in nephron epithelia including Notch target genes.
    Larman BW; Karolak MJ; Lindner V; Oxburgh L
    Cell Signal; 2012 Jan; 24(1):257-64. PubMed ID: 21945409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
    McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
    J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer.
    Sugiyama M; Oki E; Nakaji Y; Tsutsumi S; Ono N; Nakanishi R; Sugiyama M; Nakashima Y; Sonoda H; Ohgaki K; Yamashita N; Saeki H; Okano S; Kitao H; Morita M; Oda Y; Maehara Y
    Cancer Sci; 2016 Nov; 107(11):1705-1716. PubMed ID: 27589478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.
    Peignon G; Durand A; Cacheux W; Ayrault O; Terris B; Laurent-Puig P; Shroyer NF; Van Seuningen I; Honjo T; Perret C; Romagnolo B
    Gut; 2011 Feb; 60(2):166-76. PubMed ID: 21205878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-SMAD signalling output is highly regionalized in cardiovascular and lymphatic endothelial networks.
    Beets K; Staring MW; Criem N; Maas E; Schellinx N; de Sousa Lopes SM; Umans L; Zwijsen A
    BMC Dev Biol; 2016 Oct; 16(1):34. PubMed ID: 27724845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between TGF-β/SMAD and BMP/SMAD signaling pathways in the epithelial mesenchymal transition of A549 cells induced by silica.
    Yu Y; Lin Y; Yang G; Tian L
    Toxicol Mech Methods; 2018 May; 28(4):286-292. PubMed ID: 29161937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Kobayashi H; Gieniec KA; Wright JA; Wang T; Asai N; Mizutani Y; Lida T; Ando R; Suzuki N; Lannagan TRM; Ng JQ; Hara A; Shiraki Y; Mii S; Ichinose M; Vrbanac L; Lawrence MJ; Sammour T; Uehara K; Davies G; Lisowski L; Alexander IE; Hayakawa Y; Butler LM; Zannettino ACW; Din MO; Hasty J; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Wang TC; Enomoto A; Takahashi M; Worthley DL; Woods SL
    Gastroenterology; 2021 Mar; 160(4):1224-1239.e30. PubMed ID: 33197448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
    Wang L; Dai G; Yang J; Wu W; Zhang W
    Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP signaling in homeostasis, transformation and inflammatory response of intestinal epithelium.
    Wang S; Chen YG
    Sci China Life Sci; 2018 Jul; 61(7):800-807. PubMed ID: 29855793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.